Description

CD335, also known as NKp46, is a member of the natural cytotoxicity receptor (NCR) family which triggers cytotoxicity in NK cells. CD335 is direct­ly involved in target cell recognition and lysis, and is exclusively expressed on CD3^-CD56⁺ NK cells, suggesting it is a universal marker for NK cells. NKp46, along with NKp30 and NKp44, is referred to as a natural cytoxicity receptor (NCR) and plays a very important role in killing virus-infected tumor cells and MHC-class I-unprotected cells.

Formulation

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤5 microL per million cells or 5 microL per 100 microL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.

References

1. Nakajima H, et al. 2000. Eur. J. Immunol. 30:3309.
2. Kalberer CP, et al. 2003. Blood 102:127.
3. Chen Y, et al. 2007. J. Immunol. 179:2766.
4. Jarahian M, et al. 2009. J. Virol. 83:8108. PubMed
5. Correia DV, et al. 2011. Blood 118:992. (FC) PubMed
6. Achdout H. et al. 2010. J. Virol. 84:3993. (Block)
7. Lee J, et al. 2015. J Exp Med. 212:385. PubMed
8. Marquardt N, et al. 2015. J Immunol. 194:2467. PubMed